Correlation Between Abcellera Biologics and 04685A2Z3

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and 04685A2Z3 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and 04685A2Z3 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and ATH 1608 29 JUN 26, you can compare the effects of market volatilities on Abcellera Biologics and 04685A2Z3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of 04685A2Z3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and 04685A2Z3.

Diversification Opportunities for Abcellera Biologics and 04685A2Z3

0.56

Correlation Coefficient

Abcellera Biologics  04685A2Z3

Very weak diversification

The 3 months correlation between Abcellera and 04685A2Z3 is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and ATH 1608 29 JUN 26 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATH 1608 29 and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with 04685A2Z3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATH 1608 29 has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and 04685A2Z3 go up and down completely randomly.

Pair Corralation between Abcellera Biologics and 04685A2Z3

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 1.98 times more return on investment than 04685A2Z3. However, Abcellera Biologics is 1.98 times more volatile than ATH 1608 29 JUN 26. It trades about 0.04 of its potential returns per unit of risk. ATH 1608 29 JUN 26 is currently generating about -0.25 per unit of risk. If you would invest  292.00  in Abcellera Biologics on October 23, 2024 and sell it today you would earn a total of  5.00  from holding Abcellera Biologics or generate 1.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	77.78%
Values	Daily Returns

Abcellera Biologics  vs.  ATH 1608 29 JUN 26

Abcellera Biologics

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

ATH 1608 29

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ATH 1608 29 JUN 26 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for ATH 1608 29 JUN 26 investors.

Pair Trading with Abcellera Biologics and 04685A2Z3

The main advantage of trading using opposite Abcellera Biologics and 04685A2Z3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, 04685A2Z3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 04685A2Z3 will offset losses from the drop in 04685A2Z3's long position.

The idea behind Abcellera Biologics and ATH 1608 29 JUN 26 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.